Our scientific team consists of the leading global authorities on CA IX, including co-discoverers of CA IX, who have a combined joint expertise of more than 80 years on this topic.
Groundbreaking research on hypoxia has been a part of the subject for which the 2019 Nobel Prize for Medicine has been awarded; -three of our team members have co-authored recent studies on hypoxia and CA IX with one of its laureates, Sir. Peter J. Ratcliffe and still continue collaborating with him.
Professor Jaromír Pastorek is an excellent Slovak biochemist, pedagogue, and discoverer of the gene encoding a protein CA IX which serves as an endogenous marker of hypoxia in tumors. At present, prof. Pastorek is a Principal Investigator at the Biomedical Research Center of Slovak Academy of Sciences (BMC SAS). Prof. Pastorek was the President of Slovak Academy of Sciences from 2009 until 2015. Formerly he also served as the Plenipotentiary of the Slovak Government for Research and Innovation.
20 + years of operational experience in the biotechnology industry; Global leadership roles at Novartis, Takeda and Alexion, as a growth catalyst in bringing internal and external scientific developments from the lab to the market.
Cancer Research UK Professor of Medical Oncology at Oxford University, Editor-in-Chief of the British Journal of Cancer, Director of Cancer Research UK Molecular Oncology Laboratories at the Weatherall Institute of Molecular Medicine, Chairman of the CRUK Oxford Cancer Centre, joint lead of the Cancer theme of the Comprehensive Biomedical Research Centre in Oxford, fellow of the Academy of Medical Sciences
Head of department of Precision Medicine at Maastricht University.
Professor of Medicine at Cambridge and Honorary Member of the Royal College of Radiologists.
Director of the Biomedical Research Center of the Slovak Academy of Sciences, Co-discoverer of the gene encoding the CA IX.